1996
DOI: 10.1007/bf00051103
|View full text |Cite
|
Sign up to set email alerts
|

Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment?

Abstract: Calcium channel antagonists are among the world's most widely prescribed class of drugs and are used most often in patients with hypertension and coronary artery disease. However, in the recent past serious questions have been raised concerning their potentially detrimental effects. One area of considerable clinical importance that deserves close inspection is the role of calcium channel antagonists following coronary reperfusion. Specifically, is there benefit or detriment?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2001
2001

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 52 publications
(44 reference statements)
0
1
0
Order By: Relevance
“…CCB also inhibits Ca 2+ ‐mediated migration, proliferation, matrix production and necrosis in vascular smooth muscle cells [11]. The different responses induced by the agents from the same class of drugs raised questions regarding the beneficial or detrimental effects of calcium antagonists [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…CCB also inhibits Ca 2+ ‐mediated migration, proliferation, matrix production and necrosis in vascular smooth muscle cells [11]. The different responses induced by the agents from the same class of drugs raised questions regarding the beneficial or detrimental effects of calcium antagonists [12,13].…”
Section: Introductionmentioning
confidence: 99%